Thermosensitive drug delivery system of salmon calcitonin: In vitro release, in vivo absorption, bioactivity and therapeutic efficacies

Pharmaceutical Research

Volumn 27, Issue 2, 2010, Pages 272-284

  Tang, Yu ^a,b   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b SEATTLE GENETICS INC   (United States)

Author keywords

Controlled release; In vivo absorption; salmon calcitonin; Stability; Triblock copolymer

Indexed keywords

BUFFER; CALCIUM; COPOLYMER; METHYLPREDNISOLONE ACETATE; PHOSPHATE; SALCATONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; HEAT SENSITIVITY; IN VIVO STUDY; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SUSTAINED RELEASE PREPARATION;

ABSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; CALCITONIN; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; OSTEOPOROSIS; RATS; RATS, WISTAR; TEMPERATURE; TREATMENT OUTCOME;

EID: 77949270236     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-0015-z     Document Type: Article

References (39)

1. EFFO and NOF 1997 Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int 7 1
2. LJ Melton EA Chrischilles C Cooper 1992 Perspective. How many women have osteoporosis? J Bone Miner Res 7 1005 1414493
3. LJ Melton EJ Atkinson MK O'Connor 1998 Bone density and fracture risk in men J Bone Miner Res 13 1915 10.1359/jbmr.1998.13.12.1915 9844110
4. JA Kanis O Johnell A Oden 2000 Long-term risk of osteoporotic fracture in Malmo Osteoporos Int 11 669 10.1007/s001980070064 1:STN:280: DC%2BD3M%2FlsFarsw%3D%3D 11095169 (Pubitemid 30786246)
5. MM Torres A Guillermo PM Raya 2004 Calcitonin therapy in osteoporosis Treat Endocrinol 3 2 117 132 10.2165/00024677-200403020-00006 (Pubitemid 38337562)
6. GL Plosker D McTavish 1996 Intranasal salcatonin (salmon calcitonin): a review of its pharmacological properties and role in the management of postmenopausal osteoporosis Drugs Aging 8 5 378 400 10.2165/00002512-199608050- 00006 1:CAS:528:DyaK28XntVCntb8%3D 8935399
7. http://emc.medicines.org.uk/ UK Electronic Medicines Compendium accessed at 6/30/2008.
8. http://drugsaz.about.com/od/drugs/calcitonin.htm accessed at 1/11/2008.
9. http://www.emisphere.com/pp-nv-osc.asp accessed at 7/7/2006.
10. AJ Millest JR Evans JJ You Ng D Johnstone 1993 Sustained release of salmon calcitonin in vivo from lactide:glycolide copolymer depots Calcif Tissue Int 52 361 364 10.1007/BF00310200 1:CAS:528:DyaK3sXlsVKntb4%3D 8504374
11. CL Stevenson MM Tan 2000 Solution stability of salmon calcitonin at high concentration for delivery in an implantable system J Peptide Res 55 129 139 10.1034/j.1399-3011.2000.00160.x 1:CAS:528:DC%2BD3cXpslGjsg%3D%3D (Pubitemid 30079930)
12. BA Dani PP DeLuca 2001 Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres AAPS PharmSci Tech 2 4 1 7 10.1007/BF02830560
13. RVD Radersma HM Nicolas MVD Weert M Blom KD Groot JM Bezemer 2002 Stability aspects of salmoon calcitonin entrapped in poly(ether-ester) sustained release systems Int J Pharm 248 229 237 10.1016/S0378-5173(02)00458-1 (Pubitemid 35341425)
14. MG Fuentes D Torres MJ Alonso 2005 New surface-modified lipid nanoparticles as delivery for salmon calcitonin Int J Pharm 296 122 132 10.1016/j.ijpharm.2004.12.030 (Pubitemid 40693381)
15. S Prabhu LP Tran GV Betageri 2005 Effects of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants Drug Deliv 12 393 398 10.1080/10717540590968873 1:CAS:528: DC%2BD2MXhtFyitbbM 16253955 (Pubitemid 41572114)
16. MJ Whitaker J Hao OR Davies G Serhatkulu S Stolnik-Trenkic SM Howdle KM Shakesheff 2005 The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying J Control Release 101 85 92 10.1016/j.jconrel.2004.07.017 1:CAS:528:DC%2BD2cXhtVKgu7bM 15588896 (Pubitemid 39600974)
17. RH Buck F Maxl 1990 A validated HPLC assay for salmon calcitonin analysis. Comparison of HPLC and biological assay J Pharm Biomed Anal 8 761 769 10.1016/0731-7085(90)80118-9 1:CAS:528:DyaK3MXht12hsLo%3D 2100620
18. JP Meyer JT Pelton J Hoflack V Saudek 1991 Solution structure of salmon calcitonin Biopolymers 31 233 241 10.1002/bip.360310210 1:CAS:528: DyaK3MXit1eqsLg%3D 2043752
19. H Nakamuta RC Orlowski RM Epand 1990 Evidence for calcitonin receptor heterogenecity: binding studies with non-helical analogs Endocrinology 127 163 169 10.1210/endo-127-1-163 1:CAS:528:DyaK3cXlsVGnsLk%3D 2163309
20. G Siligardi B Samori S Melandri M Visconti AF Drake 1994 Correlations between biological activities and conformation properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy Eur J Biochem 221 1117 1125 10.1111/j.1432-1033.1994.tb18832.x 1:CAS:528: DyaK2cXkt1Oisro%3D 8181470
21. DF Moriarty S Vagts DP Raleigh 1998 A role for the C-terminus of calcitonin in aggregation and gel formation: a comparative study of C-terminal Fragments of human and salmon calcitonin Biochem Biophys Res Commun 245 344 348 10.1006/bbrc.1998.8425 1:CAS:528:DyaK1cXivVOqs7c%3D 9571152 (Pubitemid 28418502)
22. V Windisch F Deluccia L Duhau F Herman JJ Mencel SY Tang M Vuilhorgne 1997 Degradation pathways of salmon calcitonin in aqueous solution J Pharm Sci 86 3 359 364 10.1021/js9602305 1:CAS:528:DyaK2sXhtVGhtro%3D 9050806 (Pubitemid 27113772)
23. A Lucke J Kiermaier A Gopferich 2002 Peptide acylation by poly (α-hydroxy esters) Pharm Res 19 2 175 181 10.1023/A:1014272816454 1:CAS:528:DC%2BD38XitVSlsrw%3D 11883645 (Pubitemid 34165403)
24. S Chen J Singh 2008 Controlled release of growth hormone from thermosensitive triblock copolymer systems: in vitro and in vivo evaluation Int J Pharm 352 1-2 58 65 10.1016/j.ijpharm.2007.10.016 1:CAS:528: DC%2BD1cXitlWhtLw%3D 18036752 (Pubitemid 351284586)
25. K Al-Tahami A Meyer J Singh 2006 Poly lactic acid based injectable delivery systems for controlled release of a model protein, lysozyme Pharm Dev Technol 11 79 86 10.1080/10837450500464040 1:CAS:528:DC%2BD28XisVarurY%3D 16544911
26. E Ruel-Gariépy JC Leroux 2004 In situ-forming hydrogels-review of temperature-sensitive systems Eur J Pharm Biopharm 58 409 426 10.1016/j.ejpb.2004.03.019 15296964 (Pubitemid 39037244)
27. Y Tang J Singh 2009 Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein Int J Pharm 365 1-2 34 43 10.1016/j.ijpharm.2008.08.018 1:CAS:528:DC%2BD1cXhsVKnur%2FE 18786623
28. H Furuichi R Fukuyama N Izumo T Fujita T Kohno H Nakamuta M Koida 2000 Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats Biol Pharm Bull 23 8 946 951 1:CAS:528:DC%2BD3cXlsFams7o%3D 10963301
29. Y Wang M Ohtsuka-Isoya P Shao S Sakamoto H Shinoda 2000 Effects of methylprednisolone on bone formation and resorption in rats Jpn J Pharmcol 90 236 246 10.1254/jjp.90.236
30. Z Aydin J Akbuga 1996 Chitosan beads for the delivery of salmon calcitonin: preparation and release characteristics Int J Pharm 13 101 103 10.1016/0378-5173(95)04300-4 (Pubitemid 26143833)
31. CB Packhaeuser J Schnieders CG Oster T Kissel 2004 In situ forming parenteral drug delivery systems: an overview Eur J Pharm Biopharm 58 445 455 10.1016/j.ejpb.2004.03.003 1:CAS:528:DC%2BD2cXmsVGnsL0%3D 15296966 (Pubitemid 39037247)
32. NH Shah AS Railkar FC Chen R Tarantino S Kumar M Murjani D Palmer MH Infeld AW Malick 1993 A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) J Control Release 27 139 147 10.1016/0168-3659(93)90217-S 1:CAS:528:DyaK2cXjvVSitQ%3D%3D (Pubitemid 23328982)
33. S Chen R Pieper DC Webster J Singh 2005 Triblock copolymers: synthesis, characterization, and delivery of a model protein Int J Pharm 288 207 218 10.1016/j.ijpharm.2004.09.026 1:CAS:528:DC%2BD2cXhtFGhurrP 15620860 (Pubitemid 40038573)
34. RM Epand RF Epand RC Orlowski RJ Schlueter LT Boni SW Hui 1983 Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids Biochemistry 22 5074 5084 10.1021/bi00291a005 1:CAS:528: DyaL3sXlsFagsL8%3D 6652057
35. T Arvinte AF Drake 1993 The structure and mechanism of formation of human calcitonin fibrils J Biol Chem 268 6408 6414 1:CAS:528:DyaK3sXitVGnsLo%3D 8454613
36. MC Gaudiano M Diociaiuti P Bertocchi L Valvo 2003 Effects induced by hidroxyl radicals on salmon calcitonin: a RP-HPLC, CD and TEM study Biochimica Et Biophysica Acta 1623 33 40 1:CAS:528:DC%2BD3sXmvVOhurs%3D 12957715
37. DH Na YS Youn SD Lee MW Son WB Kim PP Deluca KC Lee 2003 Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry J Control Release 92 291 299 10.1016/S0168-3659(03)00366-3 1:CAS:528:DC%2BD3sXot1SrsLg%3D 14568410 (Pubitemid 38366152)
38. http://emc.medicines.org.uk/ UK Electronic Medicines Compendium accessed at 6/30/2008
39. T Nitta T Fukushima H Nakamuta M Koida 1999 Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin Pharmacol 79 379 386 1:CAS:528:DyaK1MXitFClt7c%3D